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Gram-negative bacteria use N-acyl L-homoserine
lactone (AHL) quorum-sensing (QS) signals to regu-
late the expression of myriad phenotypes. Non-
native AHL analogs can strongly attenuate QS
receptor activity and thereby QS signaling; however,
we currently lack a molecular understanding of the
mechanisms by which most of these compounds
elicit their agonistic or antagonistic profiles. In this
study, we investigated the origins of striking activity
profile switches (i.e., receptor activator to inhibitor,
and vice versa) observed upon alteration of the
lactone head group in certain AHL analogs. Reporter
gene assays of mutant versions of the Pseudomonas
aeruginosa QS receptor LasR revealed that interac-
tions between the ligands and Trp60, Tyr56, and
Ser129 govern whether these ligands behave as
LasR activators or inhibitors. Using this knowledge,
we propose a model for the modulation of LasR by
AHL analogs—encompassing a subtly different inter-
action with the binding pocket to a global change in
LasR conformation.
INTRODUCTION
Although bacteria were once considered simple organisms that
functioned as single cells, we now know that they often live as
multicellular societies cooperating and competing with each
other to exploit the resources in their surroundings (Schuster
et al., 2013). Any society needs communication among its mem-
bers, and bacteria use quorum sensing (QS) as a mechanism to
sense their local population densities. When a ‘‘quorum’’ of bac-
teria is reached, the microbes alter their behavior to a phenotype
that is more appropriate for a dense, cooperative environment.
Such phenotypic changes often involve secretion of substances
that can aid siblings and harm competitors (e.g., digestive en-
zymes, siderophores, and toxins; Miller and Bassler, 2001;
Schuster et al., 2013). Notably, many bacterial pathogens use
QS to initiate attack on a host only when they have amassed in
a sufficient population number to overwhelm the host response.Chemistry & Biology 21, 1361–1The link between pathogenesis and QS has attracted consider-
able recent interest to this communication network as a potential
anti-infective target (Allen et al., 2014; Bjarnsholt and Givskov,
2007; Clatworthy et al., 2007). In turn, many symbionts use QS
to initiate mutually beneficial relationships with their hosts,
perhaps most conspicuously that between legumes and nitro-
gen-fixing rhizobia (Sanchez-Contreras et al., 2007).
Among the proteobacteria, QS is mostly achieved through the
biosynthesis and subsequent concentration sensing of N-acyl
L-homoserine lactone (AHL) signals. Within a given species,
each bacterium synthesizes the same AHL constitutively at a
low level (via LuxI-type synthases). Most AHLs can freely diffuse
into and out of the cell. If the bacteria accumulate in an enclosed
environment, the AHL concentration increases until it reaches a
threshold intracellular level sufficient for productive binding and
activation of its target receptor protein (termed a LuxR-type
protein), which then alters the transcription of QS-regulated
genes (Fuqua et al., 2001; Miller and Bassler, 2001). A typical
LuxR-type protein is LasR from the opportunistic pathogen
Pseudomonas aeruginosa. When its cognate signal AHL (N-(3-
oxo)-dodecanoyl L-homoserine lactone, OdDHL, Figure 1) is
present at a quorate concentration, LasR binds this signal and
is stabilized by it in an active, dimerized form that recognizes
certain promoters and recruits transcriptional machinery to
induce QS gene expression (Sappington et al., 2011).
Because QS is dependent on the exchange of chemical sig-
nals, there is significant interest in the development of chemical
probes that can prevent QS signal-receptor binding and alter
QS outcomes. Indeed, the ability to modulate QS with non-
native molecules has tremendous implications for artificially dis-
rupting or promoting both pathogenic and mutualistic behavior
(Galloway et al., 2011, 2012; Geske et al., 2008a). The spatial
and temporal control afforded by chemical probes can enable
a deeper understanding of important microbial phenotypes
and possibly have direct therapeutic potential (Bjarnsholt and
Givskov, 2007; Clatworthy et al., 2007; Praneenararat et al.,
2012). As therapeutics, QS inhibitors have a prospective advan-
tage over traditional antibiotic therapies, because recent socio-
microbiology studies suggest that resistance is likely to spread
more slowly to QS inhibitors (that target virulence phenotypes)
than to traditional antibiotics (that target growth; Gerdt and
Blackwell, 2014; Mellbye and Schuster, 2011). As such, QS inhi-
bition is emerging as an important ‘‘antivirulence’’ approach
(Allen et al., 2014; Clatworthy et al., 2007).369, October 23, 2014 ª2014 Elsevier Ltd All rights reserved 1361
Figure 1. Impact of AHL Head Group on
Ligand Activity in LasR
(A) Two pairs of ligands that share common acyl
tails but have differing heads groups that govern
LasR activation or inhibition.
(B) View of the OdDHL binding site in the [LasR:
OdDHL]2 X-ray crystal structure (Bottomley et al.,
2007). Trp60 (highlighted in orange) hydrogen
bonds to the lactone head group of OdDHL (cyan).
Other residues that hydrogen bond with OdDHL
or are part of a hydrogen-bonding network to
OdDHL are displayed in gray. Hydrogen bonds are
displayed as black dashed lines.
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Activity Determinants of Nonlactone Ligands in LasRSome of the most well-studied chemical modulators of LasR
are AHL analogs that have altered acyl tails, altered lactone
heads, or both (Galloway et al., 2011; Hodgkinson et al., 2012;
Mattmann and Blackwell, 2010). Generally, more attention has
been given to variation in the acyl tail, but recently we and others
have synthesized nonlactone versions of AHLs with the objective
of both obtaining LasR ligands with enhanced hydrolytic stability
and expanding our understanding of the structural features of the
lactone head group that control ligand activity (Ishida et al., 2007;
Jog et al., 2006; McInnis and Blackwell, 2011a, 2011b; Morku-
nas et al., 2012; Smith et al., 2003a, 2003b). These ligands
certainly exhibit enhanced stabilities relative to lactone ana-
logs—but more interestingly, some of our nonlactone ligands
also have the opposite activity on LasR compared to their
lactone analog. For example, aniline ligand 1 (Figure 1A) is an
analog of the native activating ligand OdDHL, but it is a good in-
hibitor of LasR in reporter assays and in QS phenotypic assays
(McInnis and Blackwell, 2011a; Morkunas et al., 2012). Other
analogs of OdDHL with aniline head groups have also shown
LasR inhibitory activity (Hodgkinson et al., 2012; McInnis and
Blackwell, 2011a; Smith et al., 2003b). In addition, we observed
that thiolactone 3 (Figure 1A) is a moderate activator of LasR, in
contrast to its direct lactone analog 2, which is instead a good
inhibitor of LasR (Geske et al., 2007; McInnis and Blackwell,
2011b). These dramatic activity switches are seemingly caused
by relatively subtle changes in ligand structure; however, themo-
lecular bases for these flips in activity are unclear. In fact, there is
virtually no information about the molecular mechanisms by
which any non-native AHL analog modulates LuxR-type recep-
tors (Ahumedo et al., 2014; Chen et al., 2011). Elucidating the
causes of receptor activation versus inhibition by AHL analogs
would not only improve our understanding of themolecular foun-
dations of AHL-based QS, but would also augment our ability to
design more potent molecular probes to modulate this signaling
pathway. Toward this broad goal, we examined the origins of the
activity flipping observed for the nonlactone LasR modulators 1
and 3 in the current study.
Herein, we report our investigations of interactions of LasR
with nonlactone AHL analogs through the systematic mutagen-
esis of specific residues in the LasR native ligand binding site.
We selected the residues for modification through study of the
reported X-ray crystal structures of the LasR N-terminal ligand
binding domain (residues 1–173, out of 239) bound to OdDHL
(Bottomley et al., 2007; Zou and Nair, 2009), which permitted
us to hypothesize determinants for LasR activation or inhibition
by nonlactone AHLs. We subsequently tested these hypotheses1362 Chemistry & Biology 21, 1361–1369, October 23, 2014 ª2014 Evia reporter gene assays usingmutant LasRs. A similar mutagen-
esis approach was recently shown to be successful for studying
the interactions of AHLs bearing non-native acyl groups with
CviR, a LuxR-type receptor from Chromobacterium violaceum
(Chen et al., 2011). Because the structures of analogs 1–3 closely
approximate native AHLs, and analogs 1 and 2 act via compet-
itive inhibition, we reasoned that they would also target the
LasR ligand binding site; we therefore mutated the residues
therein (Figure 1B). We found that mutation of Trp60, Tyr56,
and Ser129 in LasR (Figure 1B) drastically flipped the activity
of alternate head group ligands 1 and 3. These observations
led to the development of a model by which AHL analogs with
different head groups exert opposite effects on LasR activity.
As this model is further refined, we believe it will inform the
design of next-generation QSmodulators with heightened activ-
ities. The flipped-activity mutations identified in this work also
have further implications—for the development of resistance to
QS inhibitors and for use in synthetic biology. We end with a dis-
cussion of these two prospects.
RESULTS AND DISCUSSION
Importance of Trp60 in Governing LasR Activation and
Inhibition by Nonlactone Ligands
Structural data for LuxR-type proteins bound to AHL ligands re-
mains very limited (Churchill and Chen, 2011). However, each
X-ray crystal structure of LasR and its homologs bound to an
AHL reveals a hydrogen bond between the Trp60 (or homolo-
gous) side chain NH and the AHL lactone carbonyl (Bottomley
et al., 2007; Chen et al., 2011; Lintz et al., 2011; Vannini et al.,
2002; Zhang et al., 2002; Zou and Nair, 2009), and the Trp60 res-
idue is highly conserved in LuxR-type proteins (Churchill and
Chen, 2011). We hypothesized that the differential activity of
alternative head-group ligands 1 and 3 toward LasR could be
derived from different interactions of their nonlactone head
groups with Trp60. To test this hypothesis, we mutated Trp60
in LasR to a phenylalanine residue, which has a smaller side
chain that lacks a hydrogen-bond donor, but retains significant
p character. We tested the activity of the mutant LasR using
a b-galactosidase reporter in an Escherichia coli background
(see Experimental Procedures). This W60F mutant was only
moderately impaired at responding to OdDHL (Table S1 avail-
able online), but the activities of ligands 1 and 3 in the W60F
mutant almost completely reverted back to the activities ex-
hibited by their lactone counterparts (OdDHL and 2, respectively)
in both wild-type andW60F LasR (Table 1). Ligand 1, which is anlsevier Ltd All rights reserved
Table 1. Activity of OdDHL and Ligands 1–3 in Wild-Type and W60F LasR
Ligands
Wild-Type W60F
Activation (%)a EC50 (nM)
b Inhibition (%)a,c IC50 (nM)
b,c Activation (%)a EC50 (nM)
b Inhibition (%)a,c IC50 (nM)
b,c
OdDHL 100 10 – – 73 75 – –
1 3d – 54d 4,800 58 1,100 17 –
2 0 – 80 510 1 – 81 3,700
3 82d 5,100 13d – 13 – 98 550
aLigands screened at 10 mM, arithmeticmean of biological triplicate is shown. No SEMexceeded 20%. Negative values for activation or inhibitionmean
the ligand is an inhibitor or activator, respectively, instead.
bGeometric mean of biological triplicate is shown. No arithmetic SEM of log-transformed data exceeded 0.14 (corresponding to an EC50 geometric
standard error of 3/O 1.4; Limpert and Stahel, 2011).
cFor inhibition, ligands were tested against EC50 of OdDHL (see Table S1).
dData previously reported (McInnis and Blackwell, 2011a, 2011b).
Chemistry & Biology
Activity Determinants of Nonlactone Ligands in LasRinhibitor of wild-type LasR, reverts to being an activator in the
W60F mutant like OdDHL. Conversely ligand 3, which activates
wild-type LasR, reverts to being an inhibitor in W60F, analogous
to ligand 2. We termed this interesting observation to be ‘‘Janus’’
behavior (after the two-faced Roman god of transitions),
because the ligands transition between two vastly different activ-
ities depending on the identity of residue 60 in LasR. Although
priormutations to LasR homologs have demonstrated altered re-
sponses to AHLs (Chen et al., 2011; Collins et al., 2006), this
observation is unique in that it involves only a single residue
replacement, and this replacement flips both an inhibitor into
an activator and an activator into an inhibitor. To verify that this
Janus activity was not an artifact of the b-galactosidase reporter,
we also tested ligands 1 and 3 in the W60F LasR mutant using a
fluorescence reporter (Moore et al., 2014), and observed the
same Janus profile. The striking reciprocal activities of these
two ligands in wild-type LasR versus mutant LasR are apparent
in Figures 2A and 2B.
Importance of Other LasR Residues in Governing
Activation or Inhibition by Nonlactone Ligands
We were interested in ascertaining whether this Janus activity
was unique to the Trp60 residue or if other hydrogen-bonding
residues were similarly important at governing nonlactone ligand
activity in LasR. We therefore mutated every residue in the LasR
ligand-binding pocket that hydrogen bonds to OdDHL or is part
of a hydrogen-bonding network with other residues that
hydrogen bond with OdDHL (as shown in the [LasR:OdDHL]2
structure; Figure 1B). The residues were mutated to amino acids
that were of comparable size but lacked hydrogen-bonding abil-
ity (Y56F, R61M, D73L, T75V, W88F, T115V, and S129A). We
constructed b-galactosidase reporters for each LasR mutant in
E. coli, analogous to the W60F LasR mutant reporter above,
and tested OdDHL and ligands 1–3 for mutant LasR activation
and inhibition in each reporter. The Y56F and S129A mutants
also showed Janus behavior (Figure 2C), but none of the other
LasR mutants displayed such flipped activity relative to wild-
type (Figure S1A). These non-Janus mutants were generally
less strongly modulated by the ligands, presumably due to a
missing polar interaction that leads to weaker ligand binding.
Interestingly, unlike the W60F mutation that caused both ligand
1 and ligand 3 to flip activity from inhibitor to activator (and
vice versa), the Y56F mutation only flipped the activity of ligand
1 from an inhibitor to an activator, and the S129A mutationChemistry & Biology 21, 1361–1only flipped the activity of ligand 3 from an activator to an inhib-
itor (Figure 2C). Ligand 3 remained an activator in the Y56F
mutant, whereas ligand 1 displayed minimal activity in the
S129Amutant. Both of the Tyr56 and Ser129 side chains engage
in hydrogen bonds with the amide carbonyl of OdDHL in the
[LasR:OdDHL]2 structure (Figure 1B). Taken together, these
LasR mutant data suggest that interactions of QS modulators
1–3 with these two amide-binding residues (Tyr56 and Ser129),
along with Trp60, are important determinants for LasR activation
and inhibition.
Trp60 has previously been hypothesized to be important for
LasR:nonlactone ligand interactions. In 2006, Jog and col-
leagues proposed that altered interactions with Trp60 could
explain why different stereoisomers of OdDHL analogs with
cyclohexanol or cyclopentanol head groups activate LasR to
different degrees (Jog et al., 2006); this study was performed
prior to the report of the [LasR:OdDHL]2 structure and was
instead based upon analysis of the structure of TraR, a LuxR-
type protein from Agrobacterium tumefaciens. In 2009, Zou
and Nair modeled the synthetic triphenyl LasR inhibitor, TP-5,
(Mu¨h et al., 2006; shown in Figure S1B) into their X-ray crystal
structure of LasR bound to an activating ligand (a related tri-
phenyl derivative, TP-3), and suggested that a possible cause
of the observed inhibitory activity for TP-5 (assuming this ligand
targets the same ligand binding site) was the poor alignment of
TP-5’s chlorine atom with the Trp60 side chain NH for a halogen
bond (Zou and Nair, 2009). We tested this hypothesis by exam-
ining the activity of TP-5 in the W60F LasR mutant. No Janus
behavior was observed for TP-5 in this mutant—its LasR inhibi-
tory activity was unchanged, and no LasR activation was
observed (Figure S1A). These data reveal that mutation of
Trp60 to Phe does not perturb interactions of TP-5 with LasR.
Other mutations to Trp60 are necessary to gain further insights
into the nature of Trp60 interactions with TP-5, if any. Neverthe-
less, these data for TP-5 indicate that this non-lactone inhibitor
may make alternate contacts with LasR relative to ligands 1–3.
Model for LasR Inhibition by Nonlactone QS Modulators
In view of the reporter strain data above, we developed a model
to explain the activation and inhibition activity of these alternate
head group ligands (1 and 3) in wild-type and mutant LasRs.
Because wild-type LasR is inhibited by ligand 1 and the W60F
mutation reverts 1 to an activator, we suspected that Trp60 inter-
acts unfavorably with the aniline head of ligand 1, which leads to369, October 23, 2014 ª2014 Elsevier Ltd All rights reserved 1363
Figure 2. ‘‘Janus’’ Ligand-Protein Behavior
(A and B) Differential activation of green-fluores-
cent protein (GFP) expression by wild-type and
W60F LasR in the presence of 10 mM ligands 1
and 3.
(C) b-galactosidase reporter assays of wild-type
LasR and three mutants with ‘‘Janus’’ behavior.
Activation assays were performed by adding
ligand at 10 mM, and activity is reporter as Miller
units on the positive y-axis. Inhibition assays were
performed by adding ligand at 10 mM and OdDHL
at its EC50 value for thatmutant (see Table S1), and
activity is reported on the negative y-axis as the
percent decrease in activity relative to only OdDHL
being present. Error bars represent SEM of a
biological triplicate.
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Activity Determinants of Nonlactone Ligands in LasRan inactive LasR conformation. The replacement of tryptophan
with the smaller phenylalanine residue relieves this unfavorable
interaction, making the binding of ligand 1 compatible with the
active conformation of LasR. To test this model at a more molec-
ular level, Autodock (Morris et al., 2009) was used to computa-
tionally dock ligand 1 into the OdDHL-binding site of wild-type
LasR and the (presumed) OdDHL-binding site of the W60F
LasR mutant. We used the [LasR:OdDHL]2 structure reported
by Bottomley and colleagues for these computational studies
(Bottomley et al., 2007; see Experimental Procedures). In agree-
ment with our model, the lowest energy poses showed that the
hydrogen ortho to the amide in the aniline head group of ligand
1 was consistently clashing with the NH of the Trp60 side chain
(Figure 3A, orange arrow), whereas the W60F mutation enabled
this ortho hydrogen to fit between two phenylalanine hydrogens
with significantly longer atom-to-atom distances (Figure 3A). We
of course are cautious to avoid firm structural conclusions based
on docking results; nonetheless, the computational study sug-
gests that Trp60 can indeed have unfavorable interactions with
the aniline head of ligand 1 that are relieved by the W60F Janus
mutation. This finding can be viewed as a ‘‘bump-hole’’ phenom-
enon (Bishop et al., 2000; Koh, 2002), where the aniline head pro-
vides a subtle ‘‘bump’’ that is sterically incompatible with Trp60
but is accommodated for by a ‘‘hole’’ formed by a tryptophan-to-
phenylalanine mutation. Bump-hole approaches to modulating
LuxR-type proteins with small molecules are yet to be reported,
and this finding with LasR and ligand 1 provides impetus for
exploration of this powerful chemical biology technique for the
study of AHL-type QS.
Regarding ligands 2 and 3, the wild-type activity data suggest
that the thiolactone head group of ligand 3 enables it to bind
wild-type LasR in a manner compatible with receptor activation,1364 Chemistry & Biology 21, 1361–1369, October 23, 2014 ª2014 Elsevier Ltd All rights reswhereas the lactone ligand 2 binds LasR
in a manner incompatible with receptor
activation (Table 1). Because the W60F
mutation abrogates this activation by
ligand 3, we suggest that the thiolactone
is able to form a favorable hydrogen-
bonding interaction that stabilizes Trp60
in LasR’s active conformation, but the
lactone of ligand 2 does not engage in
this stabilizing interaction. Although natu-ral bond order (NBO) analysis suggests that thiolactone car-
bonyls are not intrinsically better hydrogen bond acceptors
than lactone carbonyls (see Table S2), docking of 3 into the
LasR ligand binding site with Autodock (Morris et al., 2009)
showed that the larger size of the thiolactone ring in 3 can posi-
tion its carbonyl closer to the Trp60 side chain NH and also
slightly further into the pocket (Figure 3B). Therefore, a model
that matches our data and is molecularly reasonable posits
that the thiolactone ligand 3 is better positioned to hydrogen
bond with Trp60 and hold it in an orientation that stabilizes the
active LasR conformation, whereas the smaller lactone of ligand
2 is improperly positioned for this active state stabilization. The
W60F mutation causes both ligands to lose this hydrogen
bond and therefore neither can position Phe60 in a conformation
necessary for LasR activation. This model corroborates and
serves to refine the earlier proposal by Jog and colleagues
(vide supra), which invoked a prominent role for Trp60 in posi-
tioning the head groups of certain OdDHL analogs for differential
LasR activation (Jog et al., 2006).
Finally, the observed importance of residues Tyr56 and
Ser129—the side chains of which are known to hydrogen bond
to the amide carbonyl of OdDHL (Figure 1B)—can be connected
to this same model by considering how they position the ligands
near Trp60. In the case of ligand 1, Tyr56 may be essential in
holding the ligand such that the aniline head group clashes
with Trp60, allowing it to behave as a LasR inhibitor. In the
case of ligand 3, Ser129 may be essential in holding the ligand
such that the thiolactone hydrogen bonds with Trp60, thereby
engendering LasR activation.
It was still unclear howdifferent orientations of Trp60within the
ligand-binding site, presumably caused by different ligand inter-
actions, could regulate whether LasR was in an active or inactiveerved
Figure 3. Model for Trp60 Governing LasR Activation versus Inhibition
(A) Images from automated docking of ligand 1 (magenta) into wild-type and W60F LasR, displaying steric clash between ligand 1 and Trp60 (see orange arrow)
that is relieved in the W60F mutant.
(B) Image from automated docking of ligands 2 and 3 (orange and green, respectively) into wild-type LasR. Residues Tyr56 and Ser129 are shown hydrogen
bonding to the ligand amide carbonyls, and Trp60 is shown hydrogen bonding to the lactone and thiolactone carbonyls with O–H distances of 2.2 A˚ and 1.8 A˚,
respectively.
(C) Images of X-ray crystal structures of [CviR-CL]2 (Chen et al., 2011) and [LasR-OdDHL]2 (Bottomley et al., 2007). Ligands (cyan) are shown interacting with
Trp84 (CviR) and Trp60 (LasR) residues (orange), which are adjacent to residues (green) in an a helix that interacts with a binding partner (gray) in the inactive
crossed-domain [CviR-CL]2 structure (left inset). A hypothesized binding partner for LasR is displayed in transparent gray (right). Tyr56 and/or Ser129 homol-
ogous residues (blue and red, respectively) interact with the amide carbonyl to position the ligand lactone head near Trp60. Hydrogen bonds are displayed as
dashed lines.
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Activity Determinants of Nonlactone Ligands in LasRconformation. However, scrutiny of the reported X-ray structure
of CviR bound to a non-native AHL ligand (CL) provided some
insights (Chen et al., 2011). CL is a CviR antagonist, and the
[CviR:CL]2 homodimer structure revealed a crossed-domain
conformation (Figure 3C), where the ligand-binding domain of
each CviR monomer was bound to the DNA-binding domain
of the other monomer. This conformation splayed the DNA-
binding domains far apart from each other (relative to that
observed in [LuxR-type protein:native AHL]2 complexes), and
the authors proposed that this structure is unable to bind
DNA, belaying the mode of action of the antagonist CL. We
observed that in this presumably inactive conformation, CviR
engages in a protein-protein interaction adjacent to its Trp60
homologous residue (between residues Ser82, Leu85, Asp86,
and Met89 adjacent to Trp84 and residues Thr246, His247,
Ile249, and Val250 in the DNA-binding domain). We speculate
that LasR could also form a homologous inactivating protein-
protein interaction between residues near Trp60 (Ala58,
Ala59, Arg61, Glu62, Asp65, Arg66) and the LasR DNA-binding
domain or an alternative binding partner (as shown in Fig-
ure 3C). In support of this hypothesis, previous work on CviR
showed that subtly different interactions between its ligands
and Met89—a residue in the same inactivating protein-proteinChemistry & Biology 21, 1361–1interface that interacts with the acyl tail of CviR-binding
ligands—could alone drastically change whether the CviR
dimer preferred the active or inactive conformation (Chen
et al., 2011). We propose here that subtle positioning changes
to Trp60 in LasR can similarly translate to the formation of the
hypothesized inactivating protein-protein interaction. In total,
our model posits that ligands with alternative head groups
interact differently with Trp60 to alter Trp60’s conformation
enough to govern whether an adjacent inactivating protein-
protein interaction is favorable. This model is consistent with
the Janus behavior of the W60F, Y56F, and S129A mutants
with ligands 1 and 3, is logical on a molecular level, and relates
well to the recently reported model for CviR inhibition by alter-
native tail ligands (Chen et al., 2011). Further studies are
certainly necessary to test this model and are ongoing in our
laboratory. Mutagenesis of the residues hypothesized to form
inactivating protein-protein interactions near Trp60 is an impor-
tant next step, as are structural studies of both wild-type LasR
and W60F LasR bound to ligand 1. Structures of full-length
LasR, to augment the reported N-terminal ligand binding
domain structures (Bottomley et al., 2007; Zou and Nair,
2009), would be particularly revealing with regard to probing
interactions in the DNA binding domain.369, October 23, 2014 ª2014 Elsevier Ltd All rights reserved 1365
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The results reported herein yield a model to explain LasR activa-
tion and inhibition by AHL analogs with non-native head groups.
However, they also afford two other important implications. First,
the observation that a single amino acidmutation (W60F or Y56F)
can make LasR immune to QS inhibitor 1, as well as similar find-
ings with other LuxR-type proteins (Chen et al., 2011; Collins
et al., 2006), demonstrates that a likely mechanism of resistance
to QS inhibitors is mutation of LuxR-type proteins. We find it
particularly interesting that the W60F and Y56F LasR mutants
became activated by an inhibitor, which would lead to a
‘‘signal-independent’’ mechanism of QS-inhibitor resistance
(i.e., native OdDHL signal would not be required for QS activation
of themutant as long as the inhibitor-turned-activator is present).
We have recently discussed the implications of such signal-inde-
pendent QS-inhibitor resistance pathways (Gerdt and Blackwell,
2014). However, as we and others have shown, QS inhibitors
should hold a decreased spread of resistance compared to
traditional antibiotics due to the competition that arises after a
resistant bacterium appears (Gerdt and Blackwell, 2014;Mellbye
and Schuster, 2011; Schuster et al., 2013). Therefore, even
though resistance can readily develop (via the LuxR-type recep-
tor mutations examined here or other potential paths), it should
not spread easily, and the application of QS inhibitors as resis-
tance-robust microbial control agents still holds significant
promise.
The second interesting implication of the three LasR mutants
(W60F, Y56F, and S129A) is their potential use in bioengineering
applications. The emerging field of synthetic biology requires the
precise control of gene expression (Khalil and Collins, 2010). For
complex applications, this requires several orthogonal gene reg-
ulatory elements. Some of the most common inducible gene-
expression systems suffer from crosstalk and are based on
metabolic regulation, which can influence metabolism as an
undesired side effect (Lee et al., 2007). Thus AHL-based QS
systems have found significant recent utility in expanding the
toolbox of orthogonal inducible gene-expression elements
(Collins et al., 2006; Cox et al., 2007; Li et al., 2011; Tamsir
et al., 2011). A limitation of natural AHLs is their relative hydrolytic
instability (Byers et al., 2002), which is alleviated substantially by
replacing their lactone head groups with stable non-lactone var-
iants (such as 1 and 3; Hodgkinson et al., 2012; Ishida et al.,
2007; Jog et al., 2006; McInnis and Blackwell, 2011a, 2011b;
Morkunas et al., 2012; Smith et al., 2003a, 2003b). The W60F,
Y56F, and S129A LasR mutants reported herein, which respond
in opposite ways to the same nonlactone ligands, enable
methods of complex regulated gene expression that could pro-
vide for interesting experiments with mixed bacterial popula-
tions. For example, a gene in one organism could be induced
by addition of ligand 1, and then addition of ligand 3 would
both afford induction of a gene in a second organism and shut
off the first. This mixed-population ‘‘pulse-chase’’ technique
would have the benefit of not requiring the removal of the initial
signal molecule from the medium, and concomitantly uses
ligands that should not influence metabolism and are more hy-
drolytically stable than native AHLs. Many other experimental
scenarios are conceivable, as well.
In conclusion, we have delineated insights into the mecha-
nisms by which nonlactone ligands influence activation and inhi-1366 Chemistry & Biology 21, 1361–1369, October 23, 2014 ª2014 Ebition of LasR—a QS receptor that regulates the virulence of
the prevalent opportunistic pathogen P. aeruginosa. Our site-
directed mutagenesis and structural analyses provide empirical
evidence that aniline and thiolactone ligand head groups interact
differently with Trp60 relative to lactone head groups, and that
this differential interaction is sufficient to govern complete flips
between marked activation and inhibition of LasR. Based on
the [CviR:CL]2 cocrystal structure (Chen et al., 2011), we pro-
posed a model by which different interactions with Trp60 could
translate to an inactive conformation of LasR. The reported
data and model are significant because the field has practically
no information about the molecular mechanisms by which syn-
thetic activators and inhibitors interact with LasR. As this model
is further explored, we believe that it should provide insights for
the design of new synthetic LasR modulators with improved
efficacies. For example, we could intentionally design ligands
that will displace Trp60 more drastically. Alternatively, if we
discover that the hypothesized inactivating protein-protein inter-
action is in fact operative in LasR, we can attempt to rationally
stabilize or destabilize it to control LasR activity. Lastly, looking
beyond the mechanistic outcomes of this study, the exciting dis-
covery of Janus behavior between different LasR mutants both
demonstrates a mechanism by which signal-independent resis-
tance can develop to QS inhibition and holds implications for en-
gineered gene regulation.
SIGNIFICANCE
Quorum sensing (QS) is a mechanism that hundreds of bac-
terial species use to sense their population density by
detecting the concentration of secreted signal molecules.
QS regulates many virulence phenotypes in pathogens
such as Pseudomonas aeruginosa and beneficial pheno-
types in mutualistic symbionts. Therefore, the development
of potent QS modulating small molecules could have signif-
icant utility for use as experimental tools and possibly as
therapeutics. Although numerous synthetic activators and
inhibitors of N-acyl L-homoserine lactone (AHL)-type QS
have been reported, their molecular basis of activation and
inhibition is largely unknown. Subtly different molecules
can have opposite activities, and the difficulty of struc-
turally characterizing QS receptor proteins like LasR from
P. aeruginosa makes this problem challenging. We recently
identified a set of nonlactone AHL analogs with enhanced
hydrolytic stability and strong agonistic and antagonistic ac-
tivity in LasR. In the current study, we sought to investigate
how differences in the lactone heads of QS modulators can
drastically change their activity in LasR and its homologs.
We undertook mutational analysis of LasR coupled with re-
porter gene activity assays with four different ligands and
found that Trp60, Tyr56, and Ser129 are crucial in deter-
mining whether a nonlactone QS modulator is an activator
or an inhibitor of LasR. Using these data, we developed a
model to explain the mechanisms by which the ligands can
activate or inactivate LasR. Thismodel will help in the design
of improved molecular tools to control QS and the virulence
phenotypes it regulates. Additionally, our finding of a set
of ligands and mutant LasRs that present ‘‘Janus’’ activity
(i.e., individual ligands that are ‘‘two-faced’’ by inhibitinglsevier Ltd All rights reserved
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find significant utility for differentially controlling gene
expression in synthetic biology applications.
EXPERIMENTAL PROCEDURES
Compound Handling and Reagents
Stock solutions of synthetic compounds (10 mM) were prepared in DMSO and
stored at room temperature in sealed vials. OdDHL, 1, 2, and 3 were synthe-
sized as previously reported (Geske et al., 2008b; McInnis and Blackwell,
2011a, b). The synthesis and characterization of the TP-5 ligand is reported
in the Supplemental Experimental Procedures. Solvent-resistant polypro-
pylene (Corning Costar cat. no. 3790) and clear polystyrene (Corning Costar
cat. no. 3997) 96-well microtiter plates were used as appropriate.
Bacterial Strains, Media, and Growth Conditions
The bacterial strains used in this study were E. coli DH5a [F– 480dlacZDM15
D(lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rK
 mK
+) phoA supE44 l
thi-1 gyrA96 relA1] and E. coli K-12 derivative JLD271 (Lindsay and Ahmer,
2005). See the Supplemental Experimental Procedures for list of strains and
plasmids. E. coli was cultured at 37C in Luria-Bertani (LB) medium and on
LB plates with 1.5% agar. For selection and maintenance of plasmids,
gentamicin, ampicillin, and kanamycin were used at 15 mg/ml, 100 mg/ml,
and 50 mg/ml, respectively.
Construction of Mutant LasR Reporter Strains
Site-directed mutagenesis was carried out on the LasR-expressing plasmid
pJN105L (Lee et al., 2006) by overlap extension PCR (Heckman and Pease,
2007; see the Supplemental Experimental Procedures for PCR primers). The
mutagenized lasR genes were digested with EcoRI and XbaI and cloned into
EcoRI/XbaI-cut pJN105L (Lee et al., 2006). The mutant pJN105L variants
were sequenced to verify mutagenesis and transformed via electroporation
into the E. coli DH5a/pSC11 (Chugani et al., 2001) reporter strain and selected
on LB + gentamicin + ampicillin plates.
b-Galactosidase Reporter Gene Assays
All assays were conducted as previously reported (McInnis and Blackwell,
2011a, b) for the E. coli wild-type LasR strain DH5a/pJN105L + pSC11 (Lee
et al., 2006). Absorbance measurements were obtained using a Biotek
Synergy monochromator plate reader running Gen5 v1.05 software. A
600 nm filter was used for reading bacterial cell density. Filters of 420 nm
and 550 nmwere used for Miller-type absorbance assays. OdDHL EC50 values
were calculated for all LasR mutant strains (Table S1) by reported dose-
response methods (McInnis and Blackwell, 2011b). Synthetic ligands were
tested for LasR activation at 10 mM in each strain. Similarly, ligandswere tested
for LasR inhibition at 10 mM against OdDHL at its EC50 value (Table S1) for the
mutant LasR strain.
Fluorescence Microscopy
To prepare the fluorescent reporter strains, the same pJN105L-derivedmutant
plasmids were transformed into E. coli JLD271/pPROBE-KL (Moore et al.,
2014) via electroporation and selection on LB + gentamicin + kanamycin.
Microscopy was performed with a Zeiss AX10 Imager.M2 epifluorescent
microscope with a HXP 120 C Lamp using the 2.53/0.12 FLUAR objective
in conjunction with an AxioCam MR monochrome camera controlled by
AxioVision (Rel 4.8.2) software (Carl Zeiss MicroImaging). GFP filters was
used. Microscopy was performed directly through an LB agar plate containing
10 mM 1 or 3 and 0.4% arabinose after inoculation with approximately 105
colony-forming units of the E. coli fluorescent reporter strains and incubation
at 37C for 9 hr.
Ligand Docking
All four ligands discussed in this work were computationally docked into wild-
type LasR and W60F LasR structures using AutoDock v.4.2 (Morris et al.,
2009). The LasR structure was generated from the [LasR:OdDHL]2 structure
(Protein Data Bank [PDB] ID 2UV0; Bottomley et al., 2007). Using SYBYL-X
2.1.1 (Certara, L.P.), the native ligand and all water molecules were removed.Chemistry & Biology 21, 1361–1To generate the structure of the W60F mutant, Trp60 was replaced with Phe.
For both structures, all hydrogen atoms were added. The four ligands (OdDHL
and 1–3) were built and geometry optimized in Sybyl using the Powell method
with 0.05 kcal/(mol*A˚) gradients and 100 maximum iterations, using Simplex
initial optimization, Tripos force field, and Gasteiger-Huckel charges. Docking
dimensions were set in ADT Autodock Tools and were centered on the binding
pocket with a size that included the entire pocket. Autodock was then used to
dock all four ligands with 30 trials, population size of 100, random starting po-
sition and conformation, translation step range of 2.0 A˚, rotation step ranges of
50, elitism of 1,mutation rate of 0.02, crossover rate of 0.8, local search rate of
0.06, and 1,000,000 maximum energy evaluations. As a test of the docking
quality, the docking of OdDHL was compared to its position in the original
X-ray crystal structure (PDB ID 2UV0), and it was observed to overlap
extremely well (Figure S2A). The lowest energy poses that bound in the pocket
similarly to OdDHL are displayed in Figures 3A and 3B and are representative
of other low-energy poses. Ensembles of all the docking poses are shown in
Figure S2. All structural images were generated in PyMol 1.3 (Schro¨dinger).
Statistical Analysis
The error bars in all plots represent SEM from a biological triplicate.
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